45. Ianoli, P., et al. (1998). Glucocorticoids upregulate intestinal nutrient trans-port in a time-dependent substrate-specific fashion. J Gastrointest Surg, 2 (5), 449–457.
46. McGuigan, J. E. (1994). Peptic ulcer and gastritis. In K. Isselbacher et al. (eds.), Harrison’s Principles of Internal Medicine, vol. 2 (13th ed.), 1369. New York: McGraw-Hill.
47. Murray, M., & Pizzorno, J. (1998). Encyclopedia of Natural Medicine, 134–137. Rocklin, CA: Prima Publishing; van Marle, J., et al. (1981). De-glycyrrhizinised licorice (DGL) and renewal of the rat stomach epithelium. Eur J Pharmacol, 72, 219–275.
Chapter 8: Creating Pelvic Health and Power
1. Lukes, A. S., et al. (2010). Tranexamic acid treatment for heavy menstrual bleeding: A randomized controlled trial. Obstet Gynecol, 116 865–875.
2. Lepine, L. A., et al. (1997). Hysterectomy surveillance—United States, 1980–1993. MMWR, 46, 1–15.
3. Bradley, L., & Newman, J. (2000). Uterine artery embolization for treatment of fibroids: From scalpel to catheter. The Female Patient, 25, 71–78.
4. West, S. (1994). The Hysterectomy Hoax. New York: Doubleday.
5. Garcia, C. R., & Cutler, W. B. (1984). Preservation of the ovary: A reevaluation. Fertil Steril, 42 (4), 510–514.
6. Cutler, W. B. (1999). Human sex-attractant pheromones: Discovery, research, development, and application in sex therapy. Psychiat Ann, 29, 54–59.
7. Hasson, H. (1993). Cervical removal at hysterectomy for benign disease: Risks and benefits. J Reprod Med, 58 (10), 781–789.
8. Parker, W. H. (2010). Bilateral oophorectomy versus ovarian conservation: Effects on long-term women’s health. J Minim Invasive Gynecol, 17, 161–166.
9. Parker, W. H., et al. (2009). Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses’ Health Study. Obstet Gynecol, 113, 1027–1037.
10. Koushik, A., et al. (2009). Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int J Cancer, 125, 2428–2433.
11. Parker, W. H., et al. (2009). Op. cit.
12. Ibid.
13. Rivera, C. M., et al. (2009). Increased mortality for neurological and mental diseases following early bilateral oophorectomy. Neuroepidemiology, 33, 32–40.
14. Parker, W. H. (2010). Bilateral oophorectomy versus ovarian conservation: Effects on long-term women’s health. J Minim Invasive Gynecol, 17, 161–166.
15. Ibid.
16. Ibid.
17. Ibid.
18. Speroff, T., et al. (1991). A risk-benefit analysis of elective bilateral oophorectomy: Effect of changes in compliance with estrogen therapy on outcome. Am J Obstet Gynecol, 164, 65–174.
19. Carlson, K., Miller, B., & Fowler, F. (1994). The Maine Women’s Health Study. I. Outcomes of hysterectomy. Obstet Gynecol, 83, 556–565.
20. Badalian, S. S., & Rosenbaum, P. F. (2010). Vitamin D and pelvic floor disorders in women: Results from the National Health and Nutrition Examination Survey. Obstet Gynecol, 115, 795–803.
21. Martinez, R. C., et al. (2009). Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation. Microbiol Immunol, 53, 4874–4895; Martinez, R. C., et al. (2009). Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol, 48, 269–274; Anukam, K., et al. (2006). Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, double-blind, placebo controlled trial. Microbes Infect, 8, 1450–1454; Morelli, L., et al. (2004). Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clini Gastroenterol, 38, S107–S110; Reid, G., et al. (2004). Nucleic acid–based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food, 7, 223–228; Reid, G., et al. (2003). Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol, 35, 131–134; Reid, G., et al. (2003). Effect of lactobacilli oral supplement on the vaginal microflora of antibiotic treated patients: Randomized, placebo-controlled study. Nutraceuticals & Food, 8, 145–148; Gardiner, G., et al. (2002). Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications. Int Dairy J, 12, 191–196; Reid, G., et al. (2001). Probiotic lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol, 32, 37–41; Reid, G., et al. (2001). Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol, 30, 49–52.
22. Helms, J. M. (1987). Acupuncture for the management of primary dysmenorrhea. Obstet Gynecol, 69 (1), 51–56.
23. Bhatia, N., Tchou, D. C. H., et al. (1988). Pelvic floor musculature exercises in treatment of anatomical urinary stress incontinence. Phys Ther, 68, 652–655; Diokno, A. (1996). The benefits of conservative management in SUI. Contemp Urol, 8, 36–48.
24. Singla, A. (2000). An update on the management of SUI. Contemp Ob/Gyn, 45 (1), 68–85.
25. Wu, J. M., et al. (2009). Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050. Obstet Gynecol, 114, 278–283.
26. Rohner T. J., Jr., & Rohner. J. F. (1997). Urinary incontinence in America: The social significance. In P. D. O’Donnel (ed.), Urinary Incontinence. St. Louis, MO: Mosby-Yearbook, Inc.
27. Resnick, N. (1998). Improving treatment of urinary incontinence. JAMA, 280 (23), 2034–2035.
28. Pandit, M., et al. (2000). Quantification of intramuscular nerves within the female striated urogenital sphincter muscles. Obstet Gynecol, 95, 797–800.
29. Burgio, K., et al. (1998). Behavioral vs. drug treatment for urge incontinence in older women: A randomized trial. JAMA, 280 (23), 1995–2000.
30. Bergman, A., & Elia, G. (1995). Three surgical procedures for genuine stress incontinence. Five-year follow-up of a prospective randomized study. Am J Obstet Gynecol, 173, 66–71.
31. Singla, A. Op. cit., 77.
32. Glazener, C. M., & Cooper, K. (2004). Bladder neck needle suspension for urinary incontinence in women. Cochrane Database Syst. Rev., CD003636.
33. Santarosa, R. P., & Blaivas, J. G. (1994). Periurethral injection of autologous fat for the treatment of sphincteric incontinence. J Urol, 151, 607–611; Bard, C. R. (1990). PMAA submission to U.S. Food & Drug Administration for IDE #G850010.
34. Vidart, A., & Cour, F. (2010). Guidelines for the treatment of nonneurological urinary incontinence in women using periurethral balloons. Prog Urol, 20, S150–S154.
35. Carr, L. K., et al. (2008). One-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Uro-gynecol J Pelvic Floor Dysfunct, 19, 881–883.
36. Ridout, A. E., & Yoong, W. (2010). Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy. J Obstet Gynaecol, 30, 111–114.
37. Anger, J. T., et al. (2010). Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: A systematic review of the literature. J Urol, 183, 2258–2264.
38. Petrou, S. P., et al. (2009). Botulinum A toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: A phase 1/2 study. Mayo Clin Proc, 84, 702–706.
39. Burgio, K., et al. (1998). Op. cit.
40. Freedman, M., et al. (2009). Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy. Menopause, 16, 735–741.
Chapter 9: Sex and Menopause
1. Gavrilov, L. A., & Gavrilova, N. S. (Nov. 19, 2007). New findings on human longevity predictors. Paper presented at the annual meeting of the Gerontological Society of America, San Francisco, CA.
2. Lindau, S. T., et al. (2007). A study of sexuality and health among older adults in the United States.
N Engl J Med, 357, 762–774.
3. Hartmann, U., et al. (2004). Low sexual desire in midlife and older women: Personality factors, psychosocial development, present sexuality. Menopause, 11 (6, part 2), 726–740.
4. Basson, R. (2004). Recent advances in women’s sexual function and dysfunction. Menopause, 11 (6, part 2), 714–725.
5. NAMS Supplement—Update on Sexuality at Menopause and Beyond: Normative, Adaptive, Problematic, Dysfunctional. North American Menopause Society, vol. 11, no. 6 (Nov. 2004), 708–786.
6. Bancroft, J., Loftus, J., & Long, J. S. (2003). Distress about sex: A national survey of women in heterosexual relationships. Arch Sex Behav, 32 (3), 193–208.
7. Shifren, J., et al. (2008). Sexual problems and distress in United States women: Prevalence and correlates. Obstet Gynecol, 112, 970–978.
8. Wilson, D. (June 19, 2010). Drug for sexual desire disorder opposed by panel. New York Times, B3; available online at www.nytimes.com/2010/06/19/business/19sexpill.html.
9. Sarrel, P., & Whitehead, M. I. (1985). Sex and menopause: Defining the issues. Maturitas, 7, 217–224.
10. Van Lunsen, R. H., & Laan, E. (2004). Genital vascular responsiveness and sexual feelings in midlife women: Psychophysiologic, brain, and genital imaging studies. Menopause, 11 (6, part 2), 741–748.
11. Avis, N., et al. (2005). Correlates of sexual function among multi-ethnic middle-aged women: Results from the Study of Women’s Health Across the Nation (SWAN). Menopause, 12 (4), 385–398; Dennerstein, L., & Lehert, P. (2004). Women’s sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause, 11 (6, part 2), 778–785.
12. Diamond, L. M. (2008). Sexual Fluidity: Understanding Women’s Love and Desire. Cambridge, MA: Harvard University Press.
13. Brody, S. (2006). Blood pressure reactivity to stress is better for people who recently had penile-vaginal intercourse than for people who had other or no sexual activity. Biol Psychol, 71, 214–222.
14. Jankowski, M., et al. (2010). Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res Cardiol, 105, 205–218.
15. Raghunandan, C., et al. (Jan. 19, 2010; epub ahead of print). A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women. J Sex Med.
16. Bergmark, K., et al. (1999). Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med, 340, 1383–1389.
17. Savage, L. (1999). Reclaiming Goddess Sexuality, 23. Carlsbad, CA: Hay House.
18. Bodansky, S., & Bodansky, V. (2000). Extended Massive Orgasm: How You Can Give and Receive Intense Sexual Pleasure. Alameda, CA: Hunter House.
19. Love, P., & Robinson, J. (1994). Hot Monogamy: Essential Steps to More Passionate, Intimate Lovemaking, 371. New York: Dutton.
20. Hurlburth, D. F. (1991). The role of assertiveness in female sexuality: A comparative study between sexually assertive and sexually non-assertive women. J Sex Marital Ther, 12, 183–190; Hoch, Z., et al. (1981). An evaluation of sexual performance comparison between sexually dysfunctional couples. J Sex Marital Ther, 17, 90–102.
21. Zussman L., et al. (1981). Sexual responses after hysterectomyoophorectomy: Recent studies and reconsideration of psychogenesis. Am J Obstet Gynecol, 40 (7), 725–729.
22. Bachman, G. A. (1985). Correlates of sexual desire in postmenopausal women. Maturitas, 3, 211.
23. Graziottin, A., & Basson, R. (2004). Sexual dysfunction in women with premature menopause. Menopause, 11 (6, part 2), 766–777.
24. Alexander, J. L., et al. (2004). The effects of postmenopausal hormone therapies on female sexual functioning: A review of double-blind, randomized controlled trials. Menopause, 11 (6, part 2), 749–765.
25. Sarrel, P. (1990). Sexuality and menopause. Obstet Gynecol, 75 (suppl. 4), 26S–35S; Sarrel, P. (1982). Sex problems after menopause: A study of 50 married couples treated in a sex counseling programme. Maturitas, 4 (4), 231–239.
26. Van Lunsen, R. H., & Laan, E. Op. cit.
27. Sarrel, P. (1990). Op. cit.
28. Sarrel, P., et al. (1998). Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. J Reprod Med, 43 (10), 847–856; Sherwin, B., et al. (1985). Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol, 151, 153–160.
29. Davis, S. R., et al. (2008). Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med, 359, 2005–2017.
30. Love, P., & Robinson, J. (1994). Op. cit. (73–76), commenting on the study of Schreiner-Engel, P. (1981). Sexual arousability and the menstrual cycle. Psychosom Med, 43, 1999–2212.
31. Collins, G. (2000). Safe sex: Important at any age. The Female Patient, 20, 4–8.
32. Idso, C. (2009). Sexually transmitted infection prevention in newly single older women: A forgotten health promotion need. J Nurse Practitioners, 5, 440–446.
33. Love, P., & Robinson, J. (1994). Op. cit., 234–235.
Chapter 10: Nurturing Your Brain
1. Bliwise, D. L., et al. (1992). Prevalence of self-reported poor sleep in a healthy population age 50–65. Soc Sci Med, 34 (49), 49.
2. Walsh, J. K., et al. (1992). Insomnia. In S. Chokroverty (ed.), Sleep Disorders Medicine: A Comprehensive Textbook (100). Stoneham, MA: Butter-worth.
3. Knutson, K. L., et al. (2009). Association between sleep and blood pressure in midlife: The CARDIA sleep study. Arch Intern Med, 169, 1055–1061.
4. Gangwisch, J. E., et al. (2005). Inadequate sleep as a risk ractor for obesity: Analyses of the NHANES I. Sleep, 28, 1289–1296.
5. Rapkin, A., et al. (1997). Progesterone metabolite allopregnenolone in women with premenstrual syndrome. Obstet Gynecol, 90 (5), 709–714.
6. Cowden, W. L., Saenz, A., & Icaza, J. (Sept. 4–Oct. 21, 2005). The treat-ment of insomnia in patients of 4 hospitals in Guayaquil, Ecuador, using two novel herbal extracts: A double-blind, randomized, multiple crossover, placebo controlled, multicenter study. Unpublished study sponsored by Nutramedix LLC and Bionatus S. A. in Guayaquil, Ecuador; available online at www.bionatus.com/nutramedix/pages/moreinfo_babuna.html.
7. Leathwood, P. D., et al. (1985). Aqueous extract of valerian root (Valeriana officinalis L.) reduces latency to fall asleep in man. Planta Med, 54, 144–148.
8. Murray, M. (1998). 5-HTP: The Natural Way to Overcome Depression, Obesity, and Insomnia. New York: Bantam Books.
9. Holm, E., Staedt, U., Heep, J., Kortsik, C., Behne, F., Kaske, A., & Mennicke, I. (1991). Untersuchungen zum Wirkungsprofil von D, L-Kavain: Zerebrale Angriffsorte und Schlaf-Wach-Rhythmus im Tier-experiment. [The action profile of D, L-kavain: Cerebral sites and sleep-wakefulness rhythm in animals.] Arzneimittelforschung, 41 (7), 673–683; ANPA Committee on Research (2000). The use of herbal alternative medicines in neuropsychiatry: A report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci, 12, 177–192.
10. McKinlay, J. B., et al. (1987). The relative contribution of endocrine changes and social circumstances to depression in mid-aged women. J Health Soc Behav, 28, 345–363; Woods, N. F., & Mitchell, E. S. (1996). Patterns of depressed mood in midlife women: Observations from the Seattle Midlife Women’s Health Study. Res Nurs Health, 19 (2), 111–123; Martinsen, E. W. (1990). Benefits of exercise for the treatment of depression. Sports Med, 9 (6), 380–389; Morgan, J., et al. (1970). Psychological effects of chronic physical activity. Med Sci Sports, 2 (4), 213–217; Kessler, R. C., et al. (1993). Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord, 29, 85.
11. Pratt, L. (1996). Depression, psychotropic medication and risk of myocardial infarction. Circulation, 94 (12), 3123–3129; Michelson, D., et al. (1996). Bone mineral density in women with depression. N Engl J Med, 335, 1176–1181; Denollet, J., et al. (1996). Personality as independent predictor of long-term mortality in pa
tients with coronary heart disease. Lancet, 347, 417–421; Frasure-Smith, N., Lesperance, F., & Talajic, M. (1995). Depression and 18-month prognosis after myocardial infarction. Circulation, 91 (4), 999–1005.
12. Sarno, J. (1991). Healing Back Pain: The Mind-Body Connection, 26–27. New York: Warner Books; Shealy, N. (1995). Miracles Do Happen (250). Rockport, MA: Element Books.
13. Woods, N. F., Mitchell, E. S., & Adams, C. (2000). Memory functioning among midlife women: Observations from the Seattle Midlife Women’s Health Study. Menopause, 7 (4), 257–265.
14. Denollet, J., et al. (2009). Anxiety predicted premature all-cause and cardiovascular death in a 10-year follow-up of middle-aged women. J Clin Epidemiol, 62, 452–456.
The Wisdom of Menopause Page 84
